Enanta Pharmaceuticals Inc (ENTA)

[stockbettor]

A pairs trade could be envisaged of being long Gilead, while being long Enanta Pharmaceutical's on a 4:1 basis, which would provide a capital efficient hedge on Gilead if the Abbvie/Enanta regimen gains a larger than expected market share. Enanta stands to gain most from Abbvie's success, or from Gilead simply meeting or missing expectations. Once options become more liquid in Enanta this trade will be revisited for more specifics recommendations.

Buy 1 share of ENTA for every share bought in GILD. I like that rec.